CUSIP 929033207COM NEWVORQ4 2025
22 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 5.40M | $70.70M |
| 2 | Fcpm III Services B.V. | 3.62M | $47.31M |
| 3 | Frazier Life Sciences Management, L.P. | 2.54M | $33.27M |
| 4 | Fmr LLC | 2.53M | $33.04M |
| 5 | Vr Adviser, LLC | 1.94M | $25.42M |
| 6 | Paradigm Biocapital Advisors LP | 1.75M | $22.89M |
| 7 | Great Point Partners LLC | 1.37M | $17.92M |
| 8 | Nextbio Capital Management LP | 1000.0K | $13.08M |
| 9 |
| 4 | Feb 17, 2026 | Paradigm Biocapital Advisors LP | 13G/A | 4.5% | 9.23B | SEC |
| 5 | Feb 13, 2026 | Qiming Venture Partners Viii-Hc, L.P. | 13G/A | 2.8% | 1.09M | SEC |
| 6 | Feb 5, 2026 | Fmr LLC | 13G/A | 6.5% | 2.53M | SEC |
| 7 | Dec 23, 2025 | Forgrowth III Pa B.V. | 13D | 10.0% | — | SEC |
| 8 | Dec 19, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G | 5.8% | 2.26M | SEC |
| 9 | Dec 18, 2025 | Ra Capital Management, L.P. | 13D/A | 14.0% | — | SEC |
| 10 | Dec 17, 2025 | Great Point Partners, LLC | 13G | 5.6% | 1.23M | SEC |
See the full Schedule 13D/13G history for Vor Biopharma Inc.
Unlock full history| Vanguard Group Inc |
| 770.3K |
| $10.07M |
| 10 | Caligan Partners LP | 925.1K | $9.96M |